Publications by authors named "Brett Carter"

Claim this Profile
D
Development of PET/CT-clinical nomograms for predicting lymph node metastasis in primary lung cancer.
Xiaoyu Han, Wentao Li, Julie Lin, Shuoyang Li, Maliazurina B Saad, Brett W Carter

Eur Radiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients.
Morteza Salehjahromi, Hui Li, Eman Showkatian, Maliazurina B Saad, Mohamed Qayati, Brett W Carter

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC.
Maliazurina B Saad, Qasem Al-Tashi, Lingzhi Hong, Vivek Verma, Wentao Li, Brett W Carter

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence Assessment of Chest Radiographs for COVID-19.
Koji Sasaki, Guillermo Garcia-Manero, Masayuki Nigo, Elias Jabbour, Farhad Ravandi, Brett W Carter

Clin Lymphoma Myeloma Leuk· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study.
Kyaw Z Thein, Daniel D Karp, Apostolia Tsimberidou, Jing Gong, Selma Sulovic, Brett W Carter

Invest New Drugs· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct transmission sites within a synapse for strengthening and homeostasis.
Yue Yang, Man Ho Wong, Xiaojie Huang, Delia N Chiu, Yu-Zhang Liu, Brett C Carter

Sci Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Randomized Clinical Trial.
Paul M Cinciripini, Jennifer A Minnix, George Kypriotakis, Jeremy Erasmus, Diane Beneventi, Brett Carter

JAMA Intern Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun, Brett Carter

Nature· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun, Brett Carter

Nature· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular glutamate is not modulated by cannabinoid receptor activity.
Delia N Chiu, Brett C Carter

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing the Collaboration Between Imaging and Radiation Oncology.
Xun Jia, Brett W Carter, Aileen Duffton, Emma Harris, Robert Hobbs

Semin Radiat Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer.
Nicolas Zhou, Cheuk H Leung, William N William, Annikka Weissferdt, Apar Pataer, Brett W Carter

J Immunother Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.
Jacqulyne P Robichaux, Yasir Y Elamin, Zhi Tan, Brett W Carter, Shuxing Zhang

Nat Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR Appropriateness Criteria® Sepsis.

J Am Coll Radiol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synaptotagmin 7 Sculpts Short-Term Plasticity at a High Probability Synapse.
Delia N Chiu, Brett C Carter

J Neurosci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of Malignant Pleural, Pericardial, and Peritoneal Mesothelioma.
Chad D Strange, Edith M Marom, Jitesh Ahuja, Girish S Shroff, Gregory W Gladish, Brett W Carter

Adv Anat Pathol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
Maliazurina B Saad, Lingzhi Hong, Muhammad Aminu, Natalie I Vokes, Pingjun Chen, Brett W Carter

Lancet Digit Health· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial.
Mehmet Altan, Yan Wang, Juhee Song, James Welsh, Chad Tang, Brett W Carter

J Immunother Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of immunotherapy continued beyond radiographic disease progression in older adult patients with advanced non‑small cell lung cancer.
Eric K Singhi, Frank Mott, Michelle Worst, Cheuk Hong Leung, J Jack Lee, Brett Carter

Oncol Lett· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
Tina Cascone, Cheuk H Leung, Annikka Weissferdt, Apar Pataer, Brett W Carter

Nat Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.
Lingzhi Hong, Muhammad Aminu, Shenduo Li, Xuetao Lu, Milena Petranovic, Brett W Carter

Nat Commun· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer.
Shannon N Westin, Siqing Fu, Apostolia Tsimberidou, Sarina Piha-Paul, Fechukwu Akhmedzhanov, Brett Carter

Gynecol Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial.
Yufei Liu, Luyang Yao, Neda Kalhor, Brett W Carter, Mehmet Altan

Lung Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity.
Yasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, Mehmet Altan, Hai Tran

Cancer Cell· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synaptic NMDA receptor activity at resting membrane potentials.
Delia N Chiu, Brett C Carter

Front Cell Neurosci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis